Ind Swift
Fundamental Score
Ind Swift Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of INDSWFTLTD across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Attractive Valuation (P/E: 11.80 vs Industry: 33.56)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Excellent EPS Growth (18.19% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (18.19% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Strong Cash Generation (₹97.74 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (55.58%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
4 factors identified
Profit Decline Concern (-131.15%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Weak Interest Coverage (1.20x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Ind Swift
About INDSWFTLTD
Business Overview
Ind-Swift Limited develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. The company offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names. It also offers medicines for various therapeutic comprising gynaecology, pediatrics, dermatology, and other generic medicines under the Anin, Suprox, Cozy, Distone, and Oliade name. In addition, the company provides antibiotic, anti-cold, nutraceuticals, anti-diarrhoeal, anti-malarial, anti-depressants, cardiology, diabetology, anti-depressant, anti-allergic, anti- infective, neurology, and oncology. Ind-Swift Limited provides Ayurvedic products, as well as contract research and manufacturing services. The company exports its products, as well as licenses its products to Europe, Australia, Canada, South Africa, and Russia. Swift Limited was founded in 1983 and is based in Chandigarh, India. As of August 8, 2025, Ind-Swift Limited operates as a subsidiary of Ind-Swift Laboratories Limited.
Company Details
Key Leadership
INDSWFTLTD Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Ind Swift (INDSWFTLTD)?
As of 02 Jan 2026, 07:40 pm IST, Ind Swift (INDSWFTLTD) is currently trading at ₹15.71. The stock has a market capitalization of ₹92.30 (Cr).
Is INDSWFTLTD share price Overvalued or Undervalued?
INDSWFTLTD is currently trading at a P/E ratio of 11.80x, compared to the industry average of 33.56x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Ind Swift share price?
Key factors influencing INDSWFTLTD's price include its quarterly earnings growth (Sales Growth: 7.15%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Ind Swift a good stock for long-term investment?
Ind Swift shows a 5-year Profit Growth of 18.19% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of N/A before investing.
How does Ind Swift compare with its industry peers?
Ind Swift competes with major peers in the Pharmaceuticals & Biotechnology. Investors should compare INDSWFTLTD's P/E of 11.80x and ROE of N/A% against the industry averages to determine its competitive standing.
What is the P/E ratio of INDSWFTLTD and what does it mean?
INDSWFTLTD has a P/E ratio of 11.80x compared to the industry average of 33.56x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹12 for every ₹1 of annual earnings.
How is INDSWFTLTD performing according to Bull Run's analysis?
INDSWFTLTD has a Bull Run fundamental score of 45.8/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does INDSWFTLTD belong to?
INDSWFTLTD operates in the Pharmaceuticals & Biotechnology industry. This classification helps understand the competitive landscape and sector-specific trends affecting Ind Swift.
What is Return on Equity (ROE) and why is it important for INDSWFTLTD?
INDSWFTLTD has an ROE of N/A%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Ind Swift generates profits from shareholders' equity.
How is INDSWFTLTD's debt-to-equity ratio and what does it indicate?
INDSWFTLTD has a debt-to-equity ratio of N/A, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is INDSWFTLTD's dividend yield and is it a good dividend stock?
INDSWFTLTD offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has INDSWFTLTD grown over the past 5 years?
INDSWFTLTD has achieved 5-year growth rates of: Sales Growth 9.35%, Profit Growth 18.19%, and EPS Growth 18.19%.
What is the promoter holding in INDSWFTLTD and why does it matter?
Promoters hold 55.58% of INDSWFTLTD shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is INDSWFTLTD's market capitalization category?
INDSWFTLTD has a market capitalization of ₹92 crores, placing it in the Small-cap category.
How volatile is INDSWFTLTD stock?
INDSWFTLTD has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for INDSWFTLTD?
INDSWFTLTD has a 52-week high of ₹N/A and low of ₹N/A.
What is INDSWFTLTD's operating profit margin trend?
INDSWFTLTD has a 5-year average Operating Profit Margin (OPM) of 9.43%, indicating the company's operational efficiency.
How is INDSWFTLTD's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 7.15% and YoY Profit Growth of -131.15%.
What is the institutional holding pattern in INDSWFTLTD?
INDSWFTLTD has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.